Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
13 hedge funds and large institutions have $413K invested in Genetic Technologies Ltd. in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.
123% more call options, than puts
Call options by funds: $463K | Put options by funds: $208K
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
8% more funds holding
Funds holding: 12 → 13 (+1)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
44% less capital invested
Capital invested by funds: $735K → $413K (-$322K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$75.6K |
| 2 |
CA
Cetera Advisors
Denver,
Colorado
|
+$51.2K |
| 3 |
HWAM
Hennion & Walsh Asset Management
Parsippany,
New Jersey
|
+$28K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$25.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$11.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$131K |
| 2 |
VF
Virtu Financial
New York
|
-$41K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$34K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$21K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$11.3K |
GENE Hedge Fund Activity: Q4 2021 in Review
13 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q4 2021, worth a combined $413K — down 44% from $735K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new GENE positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 5 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $75.6K. The largest seller was Group One Trading, cutting an estimated $131K.
- 13 institutional investors held Genetic Technologies Ltd. (GENE) as of Q4 2021, up from 12 in Q3 2021.
- Funds reported $413K of Genetic Technologies Ltd. stock for Q4 2021, down 44% quarter-over-quarter.
- 4 funds opened new Genetic Technologies Ltd. positions in Q4 2021 and 3 closed out, a net change of +1 holder.
- The largest Genetic Technologies Ltd. buyer in Q4 2021 was Morgan Stanley, an estimated $75.6K added.
- The largest Genetic Technologies Ltd. seller in Q4 2021 was Group One Trading, an estimated $131K sold.
Based on aggregated 13F filings for Q4 2021.